Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects

Inclusion Criteria: * Male or female subjects age 18 or older scheduled for unilateral cataract surgery with posterior chamber intraocular lens implantation * If a female is of childbearing potential, the subject must agree to and submit a negative pregnancy test before any protocol-specific procedures are conducted. The subject must use effective contraception for the duration of the study. Post menopausal is defined as having no menses for at least 12 consecutive months * Signature of the subject on the Informed Consent Form * Willing to avoid disallowed medications for the duration of the study * Willing and able to follow all instructions and attend all study visits * Able to self-administer the IMP (or have a caregiver available to instill all doses of study drugs ) * Additional inclusion criteria also apply Exclusion Criteria: * Known hypersensitivity or poor tolerance to bromfenac sodium or any component of the IMP or any of the procedural medications * Currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive pregnancy test * Currently suffer from alcohol and/or drug abuse * Prior (within 30 days of beginning study treatment) or anticipated concurrent use of an investigational drug or device * A condition or a situation, which in the investigator's opinion may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation * Additional inclusion criteria also apply